Philips and MEDSI to Enter New Healthcare Technology Partnership in Russia

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) and MEDSI, Russia's largest network of private clinics, announced a strategic partnership to develop a clinical network aimed at providing efficient medical care in Russia. MEDSI president Alexey Chupin, and Peter Vullinghs, CEO of Philips in Russia and the Commonwealth of Independent States (CIS) have signed a Memorandum of Understanding (MOU) in Davos during a ceremony attended by Vladimir Evtushenkov, Chairman of the Board of Directors of Sistema Joint-Stock Financial Corporation (JSFC), and Frans van Houten, CEO of Royal Philips.

Philips and MEDSI, a leading provider of patient-centered quality care in Russia, will cooperate to achieve operational excellence at MEDSI's healthcare facilities. This new partnership goes beyond the traditional supply of innovative medical equipment and advanced technologies. It includes the access to Philips' international expertise in hospital management and the company’s conceptual understanding of hospital settings. The financial details of the partnership will not be disclosed.

The comprehensive multi-year partnership will provide MEDSI hospitals with guaranteed affordable access to the latest Philips healthcare equipment and technology, enabling MEDSI to focus on the delivery of high quality care. Philips will manage the technology and its operational performance, and provide performance management consultancy services in order to support enhanced quality of care. This business model will allow the hospitals involved to optimize their infrastructure management, patient flows and processes, and receive continuous training as well as regular system and software upgrades from Philips.

"Philips will be one of the first companies in Russia to manage such a large-scale project by providing a unified hospital solution that includes everything from design, equipment, service, patient flow management, clinical performance improvement and overall hospital management," said Peter Vullinghs. "We are extremely delighted to enter into this innovative partnership with MEDSI - the leading private healthcare provider in Russia and a very effective and dynamic organization."

"Signing of this cooperation agreement is an important step forward in MEDSI's business development and closely corresponds to our strategy of extending our clinical network and enhancing the quality of our medical services," said Alexey Chupin. "We have already achieved some good results towards this goal, and in partnership with Philips we believe we can do even more to turn our hospitals into high-tech medical institutions, where patients will receive high quality effective care based on early diagnostics in accordance with the best international quality standards."

Philips and MEDSI will cooperate in the areas of hospital renovation, full technical re-equipment of a MEDSI Clinical Hospital in Moscow's suburban area, and the building of a new clinical diagnostics center for children and adults, including a short-term in-patient hospital and children's clinical hospital. The partnership also extends to a multi-profile clinical diagnostics center for children and adults with a daytime in-patient hospital, which will be built as part of MEDSI's Clinical Hospital on Michurinsky Avenue, Moscow. It is envisaged that this complex will become a flagship hospital for the MEDSI network, showcasing the latest trends and conceptual ideas in organizing and operating a hospital.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

About MEDSI Group of Companies
The MEDSI Group of Companies is a leading national provider of medical and healthcare services in Moscow and other regions. Its network comprises 30 medical centers, of which 19 are in Moscow and the surrounding region and 11 in other parts of Russia. The Group's facilities include a clinical and diagnostic center at Belorusskaya, MEDSI International Clinic, two children's clinics and a network of fitness and wellness clubs.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

AI-Based App can Help Physicians Find Sk…

A mobile app that uses artificial intelligence, AI, to analyse images of suspected skin lesions can diagnose melanoma with very high precision. This is shown in a study led from...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...